Phathom Pharmaceuticals, Inc.

Related Filers (39)

Financials (18)

10-Q
Thursday, 11/9/2023
Quarterly Report for period ending 2023-09-30
10-Q
Thursday, 8/10/2023
Quarterly Report for period ending 2023-06-30
10-Q
Wednesday, 5/10/2023
Quarterly Report for period ending 2023-03-31
10-K
Tuesday, 2/28/2023
Annual Report for period ending 2022-12-31
10-Q/A
Wednesday, 11/9/2022
Quarterly Report for period ending 2022-09-30
10-Q
Tuesday, 11/8/2022
Quarterly Report for period ending 2022-09-30
10-Q
Tuesday, 8/2/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/10/2022
Quarterly Report for period ending 2022-03-31
10-K
Tuesday, 3/1/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/8/2021
Quarterly Report for period ending 2021-09-30
10-Q
Tuesday, 8/10/2021
Quarterly Report for period ending 2021-06-30
10-Q
Tuesday, 5/11/2021
Quarterly Report for period ending 2021-03-31
10-K
Tuesday, 3/30/2021
Annual Report for period ending 2020-12-31
10-Q
Tuesday, 11/10/2020
Quarterly Report for period ending 2020-09-30
10-Q
Thursday, 8/6/2020
Quarterly Report for period ending 2020-06-30
10-Q
Tuesday, 5/12/2020
Quarterly Report for period ending 2020-03-31
10-K
Thursday, 3/19/2020
Annual Report for period ending 2019-12-31
10-Q
Monday, 11/25/2019
Quarterly Report for period ending 2019-09-30
Show More

News (71)

8-K
Tuesday, 2/13/2024
Current report filing
8-K
Friday, 12/15/2023
Current report filing
8-K
Thursday, 12/14/2023
Current report filing
8-K
Wednesday, 12/6/2023
Current report filing
8-K
Tuesday, 11/28/2023
Current report filing
8-K
Thursday, 11/9/2023
Current report filing
8-K
Wednesday, 11/1/2023
Current report filing
8-K
Monday, 10/30/2023
Current report filing
8-K
Tuesday, 9/26/2023
Current report filing
8-K
Monday, 8/21/2023
Current report filing
8-K
Thursday, 8/10/2023
Current report filing
8-K
Monday, 7/17/2023
Current report filing
8-K
Thursday, 6/15/2023
Current report filing
8-K
Monday, 6/12/2023
Current report filing
8-K
Tuesday, 5/30/2023
Current report filing
8-K
Wednesday, 5/24/2023
Current report filing
8-K
Tuesday, 5/23/2023
Current report filing
8-K
Wednesday, 5/10/2023
Current report filing
8-K
Tuesday, 4/4/2023
Current report filing
8-K
Tuesday, 2/28/2023
Current report filing
8-K
Thursday, 2/9/2023
Current report filing
8-K
Monday, 1/9/2023
Current report filing
8-K
Tuesday, 1/3/2023
Current report filing
8-K
Wednesday, 11/9/2022
Current report filing
8-K
Tuesday, 11/1/2022
Current report filing
8-K
Monday, 10/24/2022
Current report filing
8-K
Thursday, 9/29/2022
Current report filing
8-K
Monday, 9/26/2022
Current report filing
8-K
Thursday, 8/4/2022
Current report filing
8-K
Tuesday, 8/2/2022
Current report filing
8-K
Friday, 5/27/2022
Current report filing
8-K
Wednesday, 5/25/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Wednesday, 5/4/2022
Current report filing
8-K
Wednesday, 5/4/2022
Current report filing
8-K
Tuesday, 4/26/2022
Current report filing
8-K
Monday, 3/28/2022
Current report filing
8-K
Monday, 3/14/2022
Current report filing
8-K
Tuesday, 3/1/2022
Current report filing
8-K
Wednesday, 2/9/2022
Current report filing
8-K
Tuesday, 1/25/2022
Current report filing
8-K
Monday, 11/8/2021
Current report filing
8-K
Monday, 10/18/2021
Current report filing
8-K
Monday, 9/27/2021
Current report filing
8-K
Monday, 9/20/2021
Current report filing
8-K
Wednesday, 9/8/2021
Current report filing
8-K
Tuesday, 8/10/2021
Current report filing
8-K
Thursday, 8/5/2021
Current report filing
8-K
Thursday, 7/8/2021
Current report filing
8-K
Friday, 6/4/2021
Current report filing
8-K
Tuesday, 5/25/2021
Current report filing
8-K
Tuesday, 5/11/2021
Current report filing
8-K
Thursday, 4/29/2021
Current report filing
8-K
Tuesday, 3/30/2021
Current report filing
8-K
Thursday, 12/31/2020
Current report filing
8-K
Thursday, 12/17/2020
Current report filing
8-K
Monday, 12/14/2020
Current report filing
8-K
Monday, 11/30/2020
Current report filing
8-K
Tuesday, 11/10/2020
Current report filing
8-K
Friday, 9/25/2020
Current report filing
8-K
Thursday, 8/6/2020
Current report filing
8-K
Monday, 7/13/2020
Current report filing
8-K
Monday, 6/15/2020
Current report filing
8-K
Tuesday, 5/26/2020
Current report filing
8-K
Tuesday, 5/12/2020
Current report filing
8-K
Tuesday, 5/5/2020
Current report filing
8-K
Thursday, 3/19/2020
Current report filing
8-K
Tuesday, 3/17/2020
Current report filing
8-K
Monday, 12/2/2019
Current report filing
8-K
Monday, 11/25/2019
Current report filing
8-K
Tuesday, 10/29/2019
Current report filing
Show More

Other (15)

EFFECT
Friday, 11/17/2023
Notice of Effectiveness
CORRESP
Wednesday, 11/15/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
ARS
Thursday, 4/13/2023
Annual report to security holders
SEC STAFF LETTER
Tuesday, 3/23/2021
None
SEC STAFF LETTER
Tuesday, 2/23/2021
None
EFFECT
Tuesday, 11/17/2020
Notice of Effectiveness
CORRESP
Friday, 11/13/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 10/24/2019
Notice of Effectiveness
CERT
Wednesday, 10/23/2019
Certification by an exchange approving securities for listing
CORRESP
Tuesday, 10/22/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/22/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Wednesday, 10/16/2019
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Monday, 9/30/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Tuesday, 9/10/2019
None
SEC STAFF LETTER
Tuesday, 8/13/2019
None
Show More

Ownership (188)

SC 13G/A
Monday, 2/12/2024
Carlyle Group Inc.: Major Shareholders
SC 13G/A
Friday, 2/9/2024
Invesco Ltd.: Major Shareholders
SC 13G/A
Friday, 1/26/2024
Medicxi Growth I LP: Major Shareholders
3
Friday, 1/26/2024
Medicxi Growth I LP: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 1/25/2024
TAKEDA PHARMACEUTICAL CO LTD: Major Shareholders
4
Thursday, 1/25/2024
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Monday, 1/22/2024
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Monday, 1/22/2024
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Monday, 1/22/2024
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/21/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/8/2023
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Friday, 11/3/2023
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Friday, 11/3/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Friday, 11/3/2023
Curran Terrie: Statement of changes in beneficial ownership of securities
4/A
Friday, 7/21/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2023
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2023
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
KARBE FRANK: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
Stenhouse Mark: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
Topper James N: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
Socks David A: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
COLA MICHAEL F: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
FIELDS HEIDI: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 5/26/2023
Frazier Life Sciences Public Fund, L.P.: Major Shareholders
4
Tuesday, 5/23/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 5/5/2023
Frazier Life Sciences Public Fund, L.P.: Major Shareholders
4
Tuesday, 4/11/2023
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/11/2023
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
Curran Terrie: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 3/9/2023
Carlyle Group Inc.: Major Shareholders
4
Friday, 3/3/2023
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Parikh Asit: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Avidity Partners Management LP: Major Shareholders
SC 13G/A
Friday, 2/10/2023
Flynn James E: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
VANGUARD GROUP INC: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
JANUS HENDERSON GROUP PLC: Major Shareholders
SC 13G/A
Thursday, 2/2/2023
Invesco Ltd.: Major Shareholders
SC 13G/A
Tuesday, 1/31/2023
Medicxi Growth I LP: Major Shareholders
4
Friday, 1/20/2023
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Thursday, 1/12/2023
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/23/2022
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/23/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Monday, 9/26/2022
Topper James N: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 9/26/2022
Frazier Life Sciences IX, L.P.: Major Shareholders
SC 13G
Friday, 9/23/2022
Flynn James E: Major Shareholders
4
Friday, 9/2/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Henderson Molly: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 8/11/2022
Frazier Life Sciences IX, L.P.: Major Shareholders
4
Friday, 5/27/2022
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
Stenhouse Mark: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
FIELDS HEIDI: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
Socks David A: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
KARBE FRANK: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
COLA MICHAEL F: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Monday, 5/16/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Monday, 5/16/2022
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 5/16/2022
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
4
Monday, 5/16/2022
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Monday, 5/16/2022
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/26/2022
KARBE FRANK: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/26/2022
KARBE FRANK: Initial statement of beneficial ownership of securities
3
Wednesday, 4/6/2022
Henderson Molly: Initial statement of beneficial ownership of securities
4
Wednesday, 4/6/2022
Henderson Molly: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/16/2022
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4/A
Friday, 3/11/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
4
Friday, 2/18/2022
COLA MICHAEL F: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/14/2022
Avidity Partners Management LP: Major Shareholders
SC 13G/A
Monday, 2/14/2022
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/10/2022
JANUS HENDERSON GROUP PLC: Major Shareholders
SC 13G/A
Thursday, 2/10/2022
Invesco Ltd.: Major Shareholders
SC 13G
Thursday, 2/10/2022
VANGUARD GROUP INC: Major Shareholders
SC 13G/A
Thursday, 2/10/2022
Yamada Tadataka: Major Shareholders
4
Friday, 1/21/2022
Nabulsi Azmi: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Guzzo Anthony J.: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Curran Terrie: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 11/12/2021
TAKEDA PHARMACEUTICAL CO LTD: Major Shareholders
4
Monday, 11/8/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Friday, 10/8/2021
Socks David A: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
Socks David A: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/18/2021
Socks David A: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/14/2021
Parikh Asit: Statement of changes in beneficial ownership of securities
4
Friday, 7/9/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/6/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/29/2021
Socks David A: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/29/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Friday, 6/25/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/23/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
Show More

Prospectus (20)

S-3
Thursday, 11/9/2023
Registration statement for specified transactions by certain issuers
SC TO-I/A
Monday, 7/17/2023
Issuer tender offer statement
SC TO-I
Thursday, 6/15/2023
Issuer tender offer statement
SC TO-C
Thursday, 6/15/2023
Written communication relating to an issuer or third party tender offer
424B5
Wednesday, 5/24/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 5/23/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Thursday, 3/10/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Tuesday, 10/26/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 12/17/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 12/15/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Tuesday, 11/10/2020
Registration statement for specified transactions by certain issuers
S-8
Monday, 10/28/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Monday, 10/28/2019
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Thursday, 10/24/2019
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Tuesday, 10/15/2019
General form of registration statement for all companies including face-amount certificate companies
S-1
Monday, 9/30/2019
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Wednesday, 9/18/2019
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 8/30/2019
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 8/30/2019
Correspondence Related to Draft Registration Statement
DRS
Friday, 7/26/2019
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Show More

Proxies (10)

DEF 14A
Thursday, 4/13/2023
Definitive proxy statements
DEFA14A
Thursday, 4/13/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Friday, 3/31/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Tuesday, 4/26/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Tuesday, 4/12/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Tuesday, 4/12/2022
Definitive proxy statements
DEF 14A
Tuesday, 4/6/2021
Definitive proxy statements
DEFA14A
Tuesday, 4/6/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Wednesday, 4/8/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/8/2020
Definitive proxy statements
Show More